Summary
Global Markets Direct’s, ‘SK Biopharmaceuticals Co., Ltd. - Product Pipeline Review - 2016’, provides an overview of the SK Biopharmaceuticals Co., Ltd.’s pharmaceutical research and development focus.
The report provides comprehensive information on the therapeutics under development by SK Biopharmaceuticals Co., Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
Scope
- The report provides a snapshot of the pipeline therapeutic landscape of SK Biopharmaceuticals Co., Ltd.
- The report provides overview of SK Biopharmaceuticals Co., Ltd. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses SK Biopharmaceuticals Co., Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features SK Biopharmaceuticals Co., Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
- Evaluate SK Biopharmaceuticals Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for SK Biopharmaceuticals Co., Ltd.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding SK Biopharmaceuticals Co., Ltd.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
'
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
SK Biopharmaceuticals Co., Ltd. Snapshot 6
SK Biopharmaceuticals Co., Ltd. Overview 6
Key Information 6
Key Facts 6
SK Biopharmaceuticals Co., Ltd. - Research and Development Overview 7
Key Therapeutic Areas 7
SK Biopharmaceuticals Co., Ltd. - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
SK Biopharmaceuticals Co., Ltd. - Pipeline Products Glance 12
SK Biopharmaceuticals Co., Ltd. - Late Stage Pipeline Products 12
Phase III Products/Combination Treatment Modalities 12
SK Biopharmaceuticals Co., Ltd. - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
SK Biopharmaceuticals Co., Ltd. - Early Stage Pipeline Products 15
IND/CTA Filed Products/Combination Treatment Modalities 15
Preclinical Products/Combination Treatment Modalities 16
Discovery Products/Combination Treatment Modalities 17
SK Biopharmaceuticals Co., Ltd. - Drug Profiles 18
SKL-N05 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
YKP-3089 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
relenopride hydrochloride 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
carisbamate 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
SKL-15508 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
SKL-A4R 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
SKL-PD 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
SKL-PSY 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
N-2 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
SKL-16036 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
SKL-DEP 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
SKL-G 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Small Molecule for Multiple Sclerosis 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Small Molecule for Neuropathic Pain 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Small Molecule for Tauopathies and Alzheimer's Disease 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
Small Molecule to Inhibit TDP-43 for Amyotrophic Lateral Sclerosis 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
SK Biopharmaceuticals Co., Ltd. - Pipeline Analysis 37
SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Target 37
SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Route of Administration 39
SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Molecule Type 40
SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Mechanism of Action 41
SK Biopharmaceuticals Co., Ltd. - Recent Pipeline Updates 42
SK Biopharmaceuticals Co., Ltd. - Dormant Projects 45
SK Biopharmaceuticals Co., Ltd. - Discontinued Pipeline Products 46
Discontinued Pipeline Product Profiles 46
carisbamate 46
SK Biopharmaceuticals Co., Ltd. - Locations And Subsidiaries 47
Head Office 47
Other Locations & Subsidiaries 47
Appendix 48
Methodology 48
Coverage 48
Secondary Research 48
Primary Research 48
Expert Panel Validation 48
Contact Us 48
Disclaimer 49
List of Tables
SK Biopharmaceuticals Co., Ltd., Key Information 6
SK Biopharmaceuticals Co., Ltd., Key Facts 6
SK Biopharmaceuticals Co., Ltd. - Pipeline by Indication, 2016 8
SK Biopharmaceuticals Co., Ltd. - Pipeline by Stage of Development, 2016 10
SK Biopharmaceuticals Co., Ltd. - Monotherapy Products in Pipeline, 2016 11
SK Biopharmaceuticals Co., Ltd. - Phase III, 2016 12
SK Biopharmaceuticals Co., Ltd. - Phase II, 2016 13
SK Biopharmaceuticals Co., Ltd. - Phase I, 2016 14
SK Biopharmaceuticals Co., Ltd. - IND/CTA Filed, 2016 15
SK Biopharmaceuticals Co., Ltd. - Preclinical, 2016 16
SK Biopharmaceuticals Co., Ltd. - Discovery, 2016 17
SK Biopharmaceuticals Co., Ltd. - Pipeline by Target, 2016 37
SK Biopharmaceuticals Co., Ltd. - Pipeline by Route of Administration, 2016 39
SK Biopharmaceuticals Co., Ltd. - Pipeline by Molecule Type, 2016 40
SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Mechanism of Action, 2016 41
SK Biopharmaceuticals Co., Ltd. - Recent Pipeline Updates, 2016 42
SK Biopharmaceuticals Co., Ltd. - Dormant Developmental Projects,2016 45
SK Biopharmaceuticals Co., Ltd. - Discontinued Pipeline Products, 2016 46
SK Biopharmaceuticals Co., Ltd., Other Locations 47
SK Biopharmaceuticals Co., Ltd., Subsidiaries 47
List of Figures
SK Biopharmaceuticals Co., Ltd. - Pipeline by Top 10 Indication, 2016 8
SK Biopharmaceuticals Co., Ltd. - Pipeline by Stage of Development, 2016 10
SK Biopharmaceuticals Co., Ltd. - Monotherapy Products in Pipeline, 2016 11
SK Biopharmaceuticals Co., Ltd. - Pipeline by Top 10 Target, 2016 37
SK Biopharmaceuticals Co., Ltd. - Pipeline by Route of Administration, 2016 39
SK Biopharmaceuticals Co., Ltd. - Pipeline by Molecule Type, 2016 40
SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2016 41
